Zymeworks(ZYME) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Zymeworks Strengthens Clinical Leadership With New Senior VP Appointment
TipRanksApr 21 06:32 ET
Press Release: Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
Dow JonesApr 21 06:00 ET
Express News | Zymeworks Appoints DR. Sabeen Mekan as Senior Vice President, Clinical Development
ReutersApr 21 06:00 ET
Zymeworks Inc. to Announce First Quarter 2025 Financial Results on May 8, 2025
Quiver QuantitativeApr 17 06:11 ET
Subdued Growth No Barrier To Zymeworks Inc.'s (NASDAQ:ZYME) Price
Simply Wall StApr 16 06:14 ET
Couchbase, Staar Surgical, Zymeworks, and More Stocks See Action From Activist Investors -- Barrons.com
Barron'sApr 11 15:07 ET

Comments

Teddy123

Mar 26 12:57

Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

$Zymeworks (ZYME.US)$
Game-Changing Cancer Drug Results: Zymeworks Reveals 6 Promising Treatments at AACR

Teddy123

Feb 26 19:06

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

$Zymeworks (ZYME.US)$
GSK Partnership Pays Off: How Zymeworks Just Unlocked $14 Million in Clinical Milestone Revenue

Meltyy

Nov 26, 2024 15:17

🚨 1 PDUFA this week!

See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...

7

1

Jaguar8

Jul 22, 2024 18:03

NEWS

$Zymeworks (ZYME.US)$
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
Zymeworks Inc. (Nasdaq: ZYME) announced FDA clearance of its Investigational New Drug (IND) application for ZW191, a novel folate receptor-⍺ (FR⍺) targeted topoisomerase I inhibitor antibody-drug conjugate (ADC). ZW191 targets FR⍺-expressing tumors, including ovarian, gynecological cancers, and non-small...

Jaguar8

Jun 17, 2024 19:42

NEWS

$Zymeworks (ZYME.US)$
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
Zymeworks (Nasdaq: ZYME) announced that the FDA has cleared its investigational new drug (IND) application for ZW171, a novel 2+1 T-cell targeting bispecific antibody designed to treat mesothelin (MSLN)-expressing cancers such as ovarian cancer, non-small cell lung cancer, and mesothelioma. ZW171 aims to i...

1

ZYME Zymeworks

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Monetary Policy: Navigating the Fed's Rate Cut Cycle